Panel backs lung cancer screening for some smokers

by Marilynn Marchione

Government advisers have endorsed lung cancer screening for the first time. They say certain current and former heavy smokers should get annual CT scans, a type of X-ray, to cut their chances of dying of the disease.

Monday's advice by the U.S. Preventive Services Task Force is a draft recommendation. If it becomes final as expected, it would clear the way for insurers to cover the scans. The panel recommends them for people ages 55 through 79 who smoked a pack of cigarettes a day for 30 years or the equivalent, such as two packs a day for 15 years.

Whether screening would help younger or lighter smokers is not known, so scans aren't advised for them. Scans also aren't advised for people who quit at least 15 years ago.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Task force recommends new lung cancer screening guidelines

Jun 21, 2012

A lung screening and surveillance task force, established by the American Association for Thoracic Surgery (AATS) and led by medical professionals from Brigham and Women's Hospital (BWH), is strongly recommending new guidelines ...

Lung cancer scans: False alarms amid lives saved

Jun 29, 2011

(AP) -- Full results of a big study that showed some smokers' lives could be saved by screening with lung scans now reveal more clearly what the risks are: There's a good chance of a false alarm.

Study: CT scans modestly cut lung cancer deaths

Nov 04, 2010

(AP) -- A special type of CT scan can detect lung cancer early enough to save some lives, the National Cancer Institute announced Thursday - the first evidence that a screening test may help fight the nation's top cancer ...

Recommended for you

Cancerous tumors may spread by pure chance

6 hours ago

The spreading of a cancerous tumor from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown.

Lanreotide improves survival with enteropancreatic tumors

23 hours ago

(HealthDay)—Lanreotide significantly improves survival among patients with metastatic enteropancreatic neuroendocrine tumors (grade 1 or 2), according to a study published in the July 17 issue of the New En ...

User comments